You are hereBlogs / admin's blog / Transmission of hepatitis C virus to recipients of parenteral vitamin therapy in a primary care facility.
Transmission of hepatitis C virus to recipients of parenteral vitamin therapy in a primary care facility.
Smedley EJ, Stelzer-Braid S, Ressler KA, Melling P, Bowden S, McCaw R, White PA, Vickers CR, Rawlinson WD, Ferson MJ. Transmission of hepatitis C virus to recipients of parenteral vitamin therapy in a primary care facility. J Clin Virol. 2011 Apr 18. PubMed PMID: 21507711.
Inadequate infection control was apparent and likely to have resulted in blood contamination of the healthcare workers, their equipment, the clinic environment and parenteral medications. Molecular and clinical epidemiology clearly identified parenteral transmission of HCV, highlighting the risks of blood contamination of parenteral equipment and use of multi-dose flasks on more than one patient.
Access to Parenteral Thiamine
Biological Therapies supplies a range of registered injections containing parenteral thiamine.
See the TGA website: http://www.tga.gov.au/safety/alerts-medicine-ivthiamine-100728.htm
See also the SHPA website: SHPA Manufacturers Alerts (Thiamine Injection)
